New diet for canine atopic dermatitis management announced

Article

Product created by Royal Canin North America fills an unmet need in the veterinary dermatology realm

Royal Canin North America, a company focusing on pet health nutrition, has announced the launch of Skintopic. This new diet was created to help manage canine atopic dermatitis for improved quality of life for dogs suffering from this condition, as a recent clinical trial revealed that precise nutrition can decrease itch and medication reliance in the treatment of atopic dermatitis.1

Photo courtesy of Royal Canin North America.

Photo courtesy of Royal Canin North America.

According to a company release,2 the diet features include support of sensitive skin, improvement of quality of life through itch management, and support of a strong skin barrier and immunity.

"Royal Canin is committed to making a better world for pets by putting the needs of pets at the forefront of scientific innovation," stated Jean-Lin Pelatan, general manager, Royal Canin US Veterinary Business Unit, in the release. "We are proud to introduce Skintopic, a nutritional solution for the management of atopic dermatitis, backed by robust science. We are confident this unique diet will help veterinarians provide better outcomes in atopy management.”2

One in every 10 dogs can be suffering from atopic dermatitis.3-5 In veterinary practices, dermatology cases consist of about 20% or more of a veterinarian's caseload.6 Despite how prevalent the condition is, diagnosis and finding the proper treatment plan for atopic dermatitis can pose a challenge, and owners typically visit a general practitioner various times before being referred to a dermatologist. It was also found that 73% of pet owners who visit their primary care veterinarian more than 3 times for examining their pets' skin condition “reach a tipping point of frustration.”7

Skintopic offers a solution for this dilemma as it’s a clinically proven diet supporting skin health in dogs and featuring the patented Dermauxilium complex, a unique blend of nutrients and antioxidants to help support skin quality and coat health. University of Zurich research in 2022 discovered that after 9 months on Skintopic, 82% of dogs required significantly less medication and 64% of dogs had significantly reduced itch.1

This product will be available in June 2023.

References

  1. Watson A, Rostaher A, Fischer NM, Favrot C. A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine-month controlled study. Vet Dermatol. 2022;33(1):55-e18. doi: 10.1111/vde.13020.
  2. Royal Canin North America announces launch of Skintopic to help in the management of canine atopic dermatitis. Royal Canin. January 16, 2023. Accessed January 17, 2023. https://www.prnewswire.com/news-releases/royal-canin-north-america-announces-launch-of-skintopic-to-help-in-the-management-of-canine-atopic-dermatitis-301721685.html
  3. Scott D, Miller WH, Griffin CE. Muller & Kirk's Small Animal Dermatology. 6th ed. Philadelphia, PA: W.B. Saunders Company; 2000.
  4. Olivry T, DeBoer DJ, Favrot C, et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Vet Dermatol. 2010;21(3):233-48. doi: 10.1111/j.1365-3164.2010.00889.x.
  5. Nuttall T, Uri M, Halliwell R. Canine atopic dermatitis - what have we learned? Vet Rec. 2013;172(8):201-7. doi: 10.1136/vr.f1134.
  6. Hill PB, Lo A, Eden CA, et al. Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Vet Rec. 2006;158(16):533-9. doi: 10.1136/vr.158.16.533.
  7. Hanna B. Earlier dermatology referral rewards primary care practice (part 1): easing client expenses and enhancing patient care. dvm360®. May 18, 2022. Accessed January 17, 2023. https://www.dvm360.com/view/earlier-dermatology-referral-rewards-primary-care-practice-part-1-easing-client-expenses-and-enhancing-patient-care
Recent Videos
Brittany Lancellotti, DVM, DACVD
Brittany Lancellotti, DVM, DACVD
© 2024 MJH Life Sciences

All rights reserved.